1. Home
  2. RAND vs VNRX Comparison

RAND vs VNRX Comparison

Compare RAND & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rand Capital Corporation

RAND

Rand Capital Corporation

HOLD

Current Price

$15.10

Market Cap

41.2M

Sector

Finance

ML Signal

HOLD

Logo VolitionRX Limited

VNRX

VolitionRX Limited

HOLD

Current Price

$0.30

Market Cap

38.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAND
VNRX
Founded
1969
N/A
Country
United States
United States
Employees
N/A
48
Industry
Finance: Consumer Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.2M
38.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RAND
VNRX
Price
$15.10
$0.30
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$3.17
AVG Volume (30 Days)
2.8K
2.5M
Earning Date
11-07-2025
11-13-2025
Dividend Yield
10.78%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,327,287.00
$1,472,007.00
Revenue This Year
N/A
$55.33
Revenue Next Year
N/A
$493.79
P/E Ratio
N/A
N/A
Revenue Growth
N/A
14.48
52 Week Low
$13.25
$0.27
52 Week High
$31.89
$0.94

Technical Indicators

Market Signals
Indicator
RAND
VNRX
Relative Strength Index (RSI) 64.87 40.76
Support Level $13.95 $0.27
Resistance Level $15.49 $0.33
Average True Range (ATR) 0.37 0.03
MACD 0.18 0.00
Stochastic Oscillator 82.37 53.91

Price Performance

Historical Comparison
RAND
VNRX

About RAND Rand Capital Corporation

Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. The company's investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: